Chong Kun Dang
VC Fund
Seoul, South Korea
Chong Kun Dang is a VC fund in Seoul focused on FinTech and Medical. Chong Kun Dang manufactures pharmaceutical raw materials that improve human health and prolong life. produces and sells drugs and pharmaceutical active components. It provides over-the-counter medicines, prescription medications, dietary supplements, and consumer health items.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Chong Kun Dang invests in
Stages Chong Kun Dang invests in
Countries Chong Kun Dang invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jang-han Rhee
|
|||
4 more contacts available
Investment Focus
Industry
- FinTech 1 (50%)
- Medical 1 (50%)
- Biopharma 1 (50%)
- Blockchain 1 (50%)
- Health Care 1 (50%)
Stage
- Series A 1 (50%)
- Series C 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jang-han Rhee
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
BIORCHESTRA is a developer of RNA-based therapeutics. | $45.7M / Series C / Feb 22, 2022 | |
|
|
Founded in 2012, Dunamu (CEO Lee Seok-woo) is currently providing services as the largest cryptocurrency exchange in Korea, 'Upbit' and stock trading platform based on social network, ‘Kakao Stock'. Both services are leading in the industry and ecosystems. (Upbit launched in Oct. 2017, Kakao Stock launched in Feb. 2014) Dunamuprovides the best service in the fields of cryptocurrency, securities, and asset management. Dunamu is getting much attention in both domestic and global market with professional specialists, innovative services and excellent technology. Recently, it announced to make investment of 100 billion dollars in the blockchain industry, leading the way in creating blockchain ecosystem. | $6.5M / Series A / Jun 01, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chong Kun Dang invest in?
Chong Kun Dang invests primarily in FinTech, Medical and Biopharma startups, most often at Series A and Series C stage. Most of the 2 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chong Kun Dang?
Public channels for Chong Kun Dang include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Chong Kun Dang?
The team at Chong Kun Dang includes Jang-han Rhee (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!